Learning a language is hard. Whether it’s pronunciation, accents, verb conjugation or definitions, it’s hard to wrap your ...
4 In this issue of The Lancet Oncology, another phase 2 trial conducted exclusively in China with a different HER2-targeted antibody–drug conjugate as the palliative second-line treatment of NSCLC is ...